DFX Intelligence

Data Factory

VentureFirminstitutional vcexempt_reporting_adviser

Biospring Management, LLC

Venture Capital

New York, NY

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:c6eaea3a-46af-4f1c-b78a-7b1cafe02bd3

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 6:04 AM UTC and rebuilt at most every 15 minutes.

Relationships: 34
Dated events: 3
On other graphs: 2
Observed: Sep 12, 2026 to Sep 17, 2026
41 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

RIA / Wealth Managementidentity

BIOSPRING MANAGEMENT, LLC

Registered adviser · cited, shared crd

Allocatorsidentity

Biospring Management, LLC

Manager with allocator commitments · cited, shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 9
Vintages: 2021 to 2025
Reported GAV: $284Mgross asset value on Form ADV; never dry powder
Funds with fundraising evidence: 0derived
Investments: 0
Portfolio companies: 0
Investments, 12m: 0
Partner-attributed: 0
People: 23
Investment professionals: 11derived
Co-investors: 0derived
LP relationships: 4
Stated sectors: ai,biotech,medtech,marketplaces,logistics,industrialas stated by the firm
Latest Form D: Jul 1, 2025
Latest ADV filing: Mar 27, 2026
Website: biospring.com

Funds

Fund	Vintage	Lifecycle	Form D sold	GAV	LPs
Biospring Partners 2, LP	2025	Newly closed	$10.0M	n/a	0
Biospring Partners Abz Fund V, L.P.	2022	Active deployment	$16.5M	$21.2M	0
Biospring Partners Abz Fund III, L.P.	2021	Mature	$2.1M	$5.0M	0
Biospring Partners Abz Fund IV, L.P.	2021	Mature	$2.0M	$2.6M	0
Biospring Partners Abz Fund LP	n/a	Unknown	n/a	$23.2M	0
Biospring Partners Tech I, L.P.	n/a	Wound down	n/a	$2.0M	0
Biospring Partners Fund LP	n/a	Unknown	n/a	$229M	2
Biospring Partners Fund II, L.P.	n/a	Unknown	$0	n/a	2
Biospring Partners Abz Fund II LP	n/a	Unknown	$0	$2.8M	0

Relationships

Member of firm (1)

← Biospring Management Partners, L.P.FirmSame registered website
inferenceForm ADV

Employs (22)

→ Dr. Peter HenryPersonAdvisor
factThe subject's own site
→ Dr. John SextonPersonPresident Emeritus, New York University
factThe subject's own site
→ Michelle DetwilerPersonManaging Partner
factThe subject's own site
→ Jennifer LumPersonManager And Member
Mar 1, 2020 to presentfactForm ADV, The subject's own site
→ Socrates ZachariasPersonPrincipal
factThe subject's own site
→ Chad HooperPersonOperating Partner
factThe subject's own site
→ Jordan FeykoPersonVice President
factThe subject's own site
→ Matt McBryanPersonAssociate
factThe subject's own site
→ Dr. John BaldoniPersonAdvisor
factThe subject's own site
→ Jeff BullockPersonChief Financial Officer
factThe subject's own site
→ Brian MalonePersonExecutive Vice President, Finance
factThe subject's own site
→ Drew PearsonPersonHead of Portfolio Management
factThe subject's own site
→ Billy BreedPersonDirector of Business Development
factThe subject's own site
→ Ben MorssPersonOperations Associate
factThe subject's own site
→ Precious BrownPersonOffice Manager
factThe subject's own site
→ Dr. Moncef SlaouiPersonFormer Chairman of Pharma R&D, Chairman Global R&D, Vaccines & Oncology, GSK; Operation Warp Speed
factThe subject's own site
→ Sir John BellPersonSenior Advisor
factThe subject's own site
→ Dr. David MauneyPersonFormer Managing Director, Koch Disruptive Technologies
factThe subject's own site
→ QI WangPersonCIO, Portfolio Implementation, PIMCO
factThe subject's own site
→ Dr. John LudwigPersonFormer Senior Vice President of Pharmaceutical Sciences and Global Clinical Supply at Pfizer R&D
factThe subject's own site
→ Bob PozenPersonFormer Chair, MFS; Former President, Fidelity Investments
factThe subject's own site
→ Michelle DippPersonManager And Member
Mar 1, 2020 to presentfactForm ADV

Manages (9)

→ Biospring Partners 2, LPFundInferred from principal
inferenceForm D
→ Biospring Partners Fund II, L.P.FundInferred from principal
inferenceForm D
→ Biospring Partners Abz Fund LPFundVenture Capital Fund
Jun 3, 2022 to presentfactForm ADV
→ Biospring Partners Abz Fund IV, L.P.FundVenture Capital Fund
Jun 3, 2022 to presentfactForm ADV
→ Biospring Partners Tech I, L.P.FundVenture Capital Fund
Jun 3, 2022 to presentfactForm ADV
→ Biospring Partners Abz Fund III, L.P.FundVenture Capital Fund
Jun 3, 2022 to presentfactForm ADV
→ Biospring Partners Abz Fund V, L.P.FundVenture Capital Fund
Mar 31, 2023 to presentfactForm ADV
→ Biospring Partners Abz Fund II LPFundVenture Capital Fund
Jun 3, 2022 to presentfactForm ADV
→ Biospring Partners Fund LPFundVenture Capital Fund
Jun 3, 2022 to presentfactForm ADV

Lp of (1)

← Los Angeles City Employees' Retirement SystemLimited partnerprimary
factPlan disclosure

Dated events

2 bookkeeping events (roster, classification and holdings changes) folded below

Occurred
Jun 3, 2022
Adviser's first ADV filing
Biospring Management, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)
Form ADVobserved 6 days ago

Show 2 bookkeeping events

Occurred
Mar 31, 2023
Biospring Partners Abz Fund V, L.P. first reported on Form ADV by Biospring Management, LLC (Venture Capital Fund), GAV $16,456,542
Occurred
Mar 31, 2023
Biospring Partners Tech I, L.P. no longer reported on Form ADV by Biospring Management, LLC

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 website (Form ADV), 1 work email (firm website) · as of 2026-09-17

Also named here, with no published line of their own (reach them through the firm): Dr. Peter Henry (Advisor), Dr. John Sexton (President Emeritus, New York University), Michelle Detwiler (Managing Partner), Jennifer Lum (Manager And Member), Socrates Zacharias (Principal), Chad Hooper (Operating Partner), Jordan Feyko (Vice President), Matt McBryan (Associate), Dr. John Baldoni (Advisor), Jeff Bullock (Chief Financial Officer), Brian Malone (Executive Vice President, Finance), Drew Pearson (Head of Portfolio Management).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:c6eaea3a-46af-4f1c-b78a-7b1cafe02bd3
First observed: Sep 12, 2026
Last observed: Sep 17, 2026 46 h ago
Source families: Federal regulator filings, Firm and issuer disclosures
3 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Biospring Management, LLC

Venture Capital

New York, NY

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:c6eaea3a-46af-4f1c-b78a-7b1cafe02bd3

Data as of Sep 17, 2026 (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built Sep 19, 2026, 6:04 AM UTC and rebuilt at most every 15 minutes.